Literature DB >> 8988395

Peptide selection for presentation by HLA class I: a role for the human transporter associated with antigen processing?

P M van Endert1.   

Abstract

Peptide epitopes presented by HLA class I are supplied by an elaborate system of antigen processing which subjects candidate epitopes to a process of selection according to little-understood rules. Transport of peptides from the cytosol into the endoplasmic reticulum by the TAP (transporter associated with antigen processing) complex is likely to play an important role in peptide selection for presentation. The recent development of an assay measuring substrate binding to the TAP complex has led to the identification of the major structural properties of peptides selected by the human transporter. Human TAP favors transport of peptides with structural features common to HLA class I ligands. However, TAP dislikes peptide ligands preferred by some HLA class I alleles, which may therefore frequently rely on alternative sources of peptide ligands.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8988395     DOI: 10.1007/bf02935312

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  34 in total

1.  Effect of polymorphism of an MHC-linked transporter on the peptides assembled in a class I molecule.

Authors:  S J Powis; E V Deverson; W J Coadwell; A Ciruela; N S Huskisson; H Smith; G W Butcher; J C Howard
Journal:  Nature       Date:  1992-05-21       Impact factor: 49.962

2.  Identification of a contact region for peptide on the TAP1 chain of the transporter associated with antigen processing.

Authors:  M Nijenhuis; S Schmitt; E A Armandola; R Obst; J Brunner; G J Hämmerling
Journal:  J Immunol       Date:  1996-03-15       Impact factor: 5.422

3.  Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides and the effect of flanking sequences.

Authors:  A Neisig; J Roelse; A J Sijts; F Ossendorp; M C Feltkamp; W M Kast; C J Melief; J J Neefjes
Journal:  J Immunol       Date:  1995-02-01       Impact factor: 5.422

4.  Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules.

Authors:  G Niedermann; S Butz; H G Ihlenfeldt; R Grimm; M Lucchiari; H Hoschützky; G Jung; B Maier; K Eichmann
Journal:  Immunity       Date:  1995-03       Impact factor: 31.745

5.  A viral inhibitor of peptide transporters for antigen presentation.

Authors:  K Früh; K Ahn; H Djaballah; P Sempé; P M van Endert; R Tampé; P A Peterson; Y Yang
Journal:  Nature       Date:  1995-06-01       Impact factor: 49.962

6.  Residues in TAP2 peptide transporters controlling substrate specificity.

Authors:  F Momburg; E A Armandola; M Post; G J Hammerling
Journal:  J Immunol       Date:  1996-03-01       Impact factor: 5.422

7.  A sequential model for peptide binding and transport by the transporters associated with antigen processing.

Authors:  P M van Endert; R Tampé; T H Meyer; R Tisch; J F Bach; H O McDevitt
Journal:  Immunity       Date:  1994-09       Impact factor: 31.745

Review 8.  MHC ligands and peptide motifs: first listing.

Authors:  H G Rammensee; T Friede; S Stevanoviíc
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

9.  Selectivity of MHC-encoded peptide transporters from human, mouse and rat.

Authors:  F Momburg; J Roelse; J C Howard; G W Butcher; G J Hämmerling; J J Neefjes
Journal:  Nature       Date:  1994-02-17       Impact factor: 49.962

10.  Human transporters associated with antigen processing possess a promiscuous peptide-binding site.

Authors:  M J Androlewicz; P Cresswell
Journal:  Immunity       Date:  1994-04       Impact factor: 31.745

View more
  3 in total

1.  The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage.

Authors:  Morten Nielsen; Claus Lundegaard; Ole Lund; Can Keşmir
Journal:  Immunogenetics       Date:  2005-03-03       Impact factor: 2.846

2.  Modular Three-component Delivery System Facilitates HLA Class I Antigen Presentation and CD8(+) T-cell Activation Against Tumors.

Authors:  Benjamin J Umlauf; Chin-Ying Chung; Kathlynn C Brown
Journal:  Mol Ther       Date:  2015-03-19       Impact factor: 11.454

3.  Potential immunocompetence of proteolytic fragments produced by proteasomes before evolution of the vertebrate immune system.

Authors:  G Niedermann; R Grimm; E Geier; M Maurer; C Realini; C Gartmann; J Soll; S Omura; M C Rechsteiner; W Baumeister; K Eichmann
Journal:  J Exp Med       Date:  1997-07-21       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.